Enlivex Announces $212,000,000 Private Placement to Initiate World’s First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board

Core Insights - Enlivex Therapeutics is set to implement a unique treasury strategy centered around the RAIN prediction markets token, marking it as the first publicly-listed company to do so in the U.S. [1][8] - The company is continuing the clinical development of Allocetra™, a therapy aimed at treating knee osteoarthritis, addressing a significant unmet medical need in a growing market [2][9] - The private placement transaction involves the sale of 212 million ordinary shares at $1.00 per share, yielding approximately $212 million in gross proceeds [3] Company Developments - Enlivex will appoint former Italian Prime Minister Matteo Renzi to its Board of Directors following the private placement [2] - The company plans to utilize the net proceeds from the PIPE transaction to implement the RAIN treasury strategy while maintaining focus on its core business operations [3][5] - The price per share for the private placement represents an 11.5% premium over the previous closing price [2] Industry Context - The prediction markets sector is experiencing significant institutional interest, highlighted by a $2 billion investment in Polymarket and a $300 million financing round for Kalshi [5] - RAIN is described as a fully decentralized predictions and options protocol, allowing users to create and trade custom options on various markets [4] - The market for osteoarthritis treatments is substantial, with over 32.5 million Americans affected and projections indicating that 78 million Americans may have osteoarthritis by 2040 [9]